PATENT CLAIM ANALYSIS

Application Number: 16000300
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-03
Patent Classification: ["514", "005900"]

Abstract:
The present invention provides therapeutic agents and compositions comprising elastin-like peptides (ELPs) and therapeutic proteins. In some embodiments, the therapeutic protein is a GLP-1 receptor agonist, insulin, or Factor VII/VIIa, including functional analogs. The present invention further provides encoding polynucleotides, as well as methods of making and using the therapeutic agents. The therapeutic agents have improvements in relation to their use as therapeutics, including, inter alia, one or more of half-life, clearance and/or persistence in the body, solubility, and bioavailability.

Claim (Index 113):
1The method of  claim 112 , wherein the improved function is improved epithelial cell proliferation in the intestine.

Metadata:
- Claim Count in Document: 291.0
- Percentile: 94.0
- Lexical Diversity: 1.56452
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14822512', '13445979', '12493912', '13524812', '12852365']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8691510661403784
- 35 USC 102 Novelty (BERT): 0.5554720106623147
- Combined Prediction Score: 0.8377831605925721
- Mean Citation Score: 618.8178019999998
- Max Citation Score: 652.1809
- Similarity Product: 281.2087212164104

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test